Nancy Robles

Nurse Practitioner, specializing in inherited cardiovascular disease and advanced heart failure. Hablo Español.

[Nancy Robles @ncyrobles]

Observing a drug's journey from development to implementation has been a remarkable experience. #HCM #SCICD
https://t.co/CYyowh5o9Q

[Stanford Medicine @StanfordMed]

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
https://t.co/hUM4706aAN

[Nancy Robles @ncyrobles]

Join me and the one and only, the legend, @cindyluzy at the 2025 MyHeartCounts 5k! Every step you take supports research and access for families affected by genetic heart disease. !🧬🏃🏻‍♀️♥️👩🏻‍🔬
#MyHeartCounts #stanfordhealthcare
REGISTER HERE https://t.co/IgBlhPFAQU

[Victoria Parikh, MD @vnparikh]

Happy ❤️Month! Join me and @alyelezaby at the Stanford Medicine My Heart Counts 5K, kids fun run and cycling event to support families with 🫀disease!

https://t.co/RyybFMII1k

https://t.co/W8SJg7Y48a

[euan ashley @euanashley]

Thanks to Sports Illustrated for featuring our work on the molecular adaptations to exercise!

[euan ashley @euanashley]

Come join us for the annual My Heart Counts walk-run around Stanford campus! Raise money for an amazing cause!

[Victoria Parikh, MD @vnparikh]

We are just so thrilled to launch our new center website! Check out all the cool stuff we're doing in CV genetics at the Stanford Center for Inherited Cardiovascular Disease (#SCICD): https://t.co/RMQoOXyimG

[Nancy Robles @ncyrobles]

@StanfordDeptMed @euanashley Congratulations Euan!

[Stanford Department of Medicine @StanfordDeptMed]

We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley @euanashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.

[Victoria Parikh, MD @vnparikh]

The Stanford Center for Inherited Cardiovascular Disease (SCICD) is putting on our annual fundraising 5K! Please consider running or donating to support these brave families through out research and patient care. https://t.co/gsAVNhzSxt

[Nancy Robles @ncyrobles]

https://t.co/5fY5E7S7Ks

[euan ashley @euanashley]

Nice feature on the bench to bedside story that is myosin inhibition for hypertrophic cardiomyopathy - a game changing therapeutic approach!

https://t.co/Yqh3EoR9jJ

[Nancy Robles @ncyrobles]

@Dr_Oubre @CoreyMatzkanin @lznamie @campas760 @ChristyDeeee @megan_myers @jordon896 @arnpcyd @HeartRhythmNP @nrsewells @samiiiig @WhitmireDnp @nebraska_np @ShannonE_CNP @FinnZinn @ChristyMaPAC @wmp0222 @crankycarl1 @maryfdavey @dillsaurus You’re are trained and qualified for this. Don’t let impostor syndrome influence your confidence.

[Tia Moscarello @TiaMoscarello]

Last but not least: Dr. @tikuowens will be presenting NEXT WEEK, May 18 from 12-1pm Pacific Time. The topic is a timely one: Cardiac Myosin Inhibitors for Treatment of HCM. Register here: https://t.co/0SYzFtYICN (cat 1 CEUs available #gcchat)

[Nancy Robles @ncyrobles]

@TiaMoscarello @tikuowens Looking forward to this presentation! #HCM

[euan ashley @euanashley]

A landmark day for patients with hypertrophic cardiomyopathy!

The story began with basic insights into myosin biology from Jim Spudich @Stanford

Rapid biotech development at Myokardia led to successful Phase 1-3 (first patient dosed at Stanford!).

https://t.co/W5bV64bX2p

[Matthew Wheeler @MWheelerMD]

Excited to see #mavacamten approval for patients with symptomatic obstructive hypertrophic cardiomyopathy! Spudich lab @stanford fundamental biophysics facilitating MyoKardia small molecule, trials @StanfordMed since 2015 - SAD, EXPLORER, VALOR, MAVA-LTE…more work to be done 1/4

[Nancy Robles @ncyrobles]

@bmsnews Amazing!!!! 🎉🫀💊

[Bristol Myers Squibb @bmsnews]

#MEDIA: Announcing #FDA approval of first-in-class treatment for adults living with symptomatic NYHA class II-III obstructive hypertrophic cardiomyopathy (symptomatic obstructive #HCM). Learn more: https://t.co/c4FFWIW7hj